
world without disease
Johnson & Johnson Innovation Invests US$3.9 Million In Singapore R&D
Three Singapore-based teams working on myopia, cancer and liver disease will receive funding over the next three years.

Three Singapore-based teams working on myopia, cancer and liver disease will receive funding over the next three years.